PCM
HOLX

Piermont Capital Management’s Hologic HOLX Stock Holding History

Piermont Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,940
Closed -$586K – 264
2016
Q2 		$586K Buy
16,940
+9,830
+138% +$340K 0.15% 218
2016
Q1 		$245K Hold
7,110
– – 0.08% 220
2015
Q4 		$275K Hold
7,110
– – 0.09% 202
2015
Q3 		$278K Sell
7,110
-4,820
-40% -$191K 0.09% 197
2015
Q2 		$454K Hold
11,930
– – 0.14% 177
2015
Q1 		$394K Buy
+11,930
New +$366K 0.12% 189

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Piermont Capital Management's HOLX Position: Q3 2016 in Review

Piermont Capital Management sold out of Hologic (HOLX) in Q3 2016, closing a stake of 16,940 shares — an estimated $586K sold.

Piermont Capital Management first reported a position in HOLX in Q1 2015 and held it in 6 quarters. The position peaked at $586K in Q2 2016. 470 funds tracked by Wall St. Rank hold HOLX as of Q3 2016.

  • Piermont Capital Management reported no remaining Hologic position as of Q3 2016 after selling out during the quarter.
  • Piermont Capital Management sold 16,940 Hologic shares in Q3 2016, an estimated $586K.
  • Piermont Capital Management first reported a position in Hologic in Q1 2015 and held it in 6 quarters.
  • Piermont Capital Management's Hologic position peaked at $586K in Q2 2016.
  • 470 funds tracked by Wall St. Rank held Hologic as of Q3 2016.

Based on Piermont Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.